VNDR

Virtual Non-Deal Roadshow - TSX-V: GXU | OTCQB: GVXXF - Mar 2, 2021

GoviEx is a mineral resource company focused on the exploration and development of uranium properties in Africa. GoviEx’s principal objective is to become a significant uranium producer through the continued exploration and development of its flagship mine-permitted Madaouela Project in Niger, its mine-permitted Mutanga Project in Zambia, and its other uranium properties elsewhere in Africa.

GoviEx Uranium Inc.

Virtual Non-Deal Roadshow - TSX-V: ONE | OTCQB: OONEF - Feb 26, 2021

Established in 1992, 01 Communique is always at the forefront of technology. Its latest innovation is on cyber security with the development focus on Quantum-Safe Cryptography. 01's patent-pending Quantum-Safe Cryptography is designed to operate on classical computer systems as we know them today while at the same time secure enough to safeguard against potential cyber attacks from quantum computers.

01 Communique's common shares are listed on the TSX Venture Exchange (TSX-V) under the symbol 'ONE' and quoted on the OTCQB market under the symbol ‘OONEF’.

The Company’s legacy business provides its customers with a suite of secure remote access services and products. Our innovations are protected by a number of Patents in various countries. As the digital and mobile technologies evolve, 01 continues to provide cost effective and reliable solutions that give businesses and consumers anytime anywhere remote access to information stored on a desktop computer.

01 Communique Laboratory Inc.

Virtual Non-Deal Roadshow - TSX: HLS - Feb 25, 2021

HLS Therapeutics Inc. (TSX:HLS) is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. We focus on products targeting the central nervous system and cardiovascular therapeutic areas. Our management team is comprised of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.

HLS Therapeutics focuses on the North American market and has operational locations in Toronto (Etobicoke, Ontario), Montreal (Dorval, Quebec) and Philadelphia (Rosemont, Pennsylvania). We source our products from the drug’s originator or from best-in-class manufacturing partners, ensuring our brands are manufactured with the highest standards of quality and in compliance with FDA and Health Canada’s regulations.

HLS Therapeutics Inc.

Virtual Non-Deal Roadshow: TSX-V: NAM | OTCQB: NMTLF - Feb 25, 2021

New Age Metals Inc. is a mineral exploration and development company focused on the discovery, exploration and development of green metal projects in North America. The Company has two divisions; a Platinum Group Metals division and a Lithium/Rare Element division. The PGM division includes the 100% owned River Valley Project, one of North America’s largest undeveloped Primary Palladium Projects, situated 100 km from Sudbury, Ontario as well as the Genesis PGM Project in Alaska. The Lithium division is the largest mineral claim holder in the Winnipeg River Pegmatite Field, where the Company is exploring for hard rock lithium and various rare elements such as tantalum and rubidium. Our philosophy is to be a project generator with the objective of optioning our projects with major and junior mining companies through to production. The Company is actively seeking an option/ joint venture partner for its road-accessible Genesis PGM project in Alaska and for our Lithium division in Manitoba.

New Age Metals Inc.

Virtual Non-Deal Roadshow - TSX-V: FPX- Feb 24, 2021

FPX Nickel is a Vancouver-based junior nickel mining company developing the large-scale Decar Nickel District in central British Columbia. Decar hosts the Baptiste deposit, which has the potential to become one of the largest nickel mines the world. A recent preliminary economic assessment (PEA) on Baptiste forecasts annual production of 99 million pounds of nickel over a 35-year mine life at an operating cost of US$2.74, which would make Baptiste one of the world's largest and lowest-cost nickel mines. Further work is planned in 2021 to advance the Baptiste project toward the prefeasibility study stage, and for a maiden drill program at the the large-scale Van Target at Decar, which has the potential to host a deposit that is larger and higher-grade than Baptiste.

FPX Nickel Corp.

Virtual Non-Deal Roadshow - TSX: CRDL | OTCQX: CRTPF - Feb 24, 2021

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease. The Company recently received approval from the U.S. FDA for its Investigational New Drug (IND) application to commence a Phase II/III, double-blind, placebo-controlled clinical trial investigating the efficacy and safety of its lead product, CardiolRx™, in hospitalized COVID-19 patients with a prior history of, or risk factors for, cardiovascular disease. CardiolRx™ is an ultra-pure, high concentration cannabidiol oral formulation that is pharmaceutically produced, manufactured under cGMP, and THC free (<10 ppm).

Cardiol is also planning a Phase II international trial of CardiolRx™ in acute myocarditis, a condition caused by inflammation in heart tissue, which remains the most common cause of sudden cardiac death in people less than 35 years of age, and is developing a proprietary subcutaneous cannabidiol formulation for the treatment of inflammation in the heart that is associated with the development and progression of heart failure. Heart failure is the leading cause of death and hospitalization in North America, with associated annual healthcare costs in the U.S. alone exceeding $30 billion.

While advancing important clinical trials in inflammatory heart disease, Cardiol is generating a near-term revenue opportunity in the growing Canadian medical cannabinoid market – currently exceeding $600 million annually – with its recently launched commercial product, Cortalex™, www.cortalex.com. Cortalex is the first THC-free extra-strength formulation of cannabidiol oil available across Canada exclusively online at Medical Cannabis by Shoppers™ https://cannabis.shoppersdrugmart.ca/.

For further information about Cardiol Therapeutics, please visit cardiolrx.com.

Cardiol Therapeutics Inc.

Virtual Non-Deal Roadshow - TSX: GMX | OTCQX: GLBXF - Feb 23, 2021

GLOBEX is a Toronto Stock Exchange, Frankfurt and OTCQX-listed corporation with a diversified North American portfolio of mid-stage exploration, development and royalty properties containing: Precious Metals (gold, silver, platinum, palladium), Base Metals (copper, zinc, lead, nickel), Specialty Metals and Minerals (manganese, titanium oxide,iron, molybdenum, uranium, lithium, rare earths) and Industrial Minerals and Compounds (mica, silica, apatite, talc, magnesite).

Globex explores for its own account and options many of its numerous projects to other companies which pay Globex cash, shares and a royalty and undertake extensive exploration in order to earn an interest in Globex's projects.

Globex Mining Enterprises Inc.

Virtual Non-Deal Roadshow - TSX-V: MPH- Feb 23, 2021

Medicure Inc., a pharmaceutical company, engages in the research, development, and commercialization of therapies for the cardiovascular market in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia; and ReDS, a non-invasive medical device that provides measurement of lung fluid for the management of congestive heart failure, as well as Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. The company was founded in 1997 and is headquartered in Winnipeg, Canada

Medicure Inc.

Virtual Non-Deal Roadshow - TSX-V: ONE | OTCQB: OONEF - Feb 22, 2021

Established in 1992, 01 Communique is always at the forefront of technology. Its latest innovation is on cyber security with the development focus on Quantum-Safe Cryptography. 01's patent-pending Quantum-Safe Cryptography is designed to operate on classical computer systems as we know them today while at the same time secure enough to safeguard against potential cyber attacks from quantum computers.

01 Communique's common shares are listed on the TSX Venture Exchange (TSX-V) under the symbol 'ONE' and quoted on the OTCQB market under the symbol ‘OONEF’.

The Company’s legacy business provides its customers with a suite of secure remote access services and products. Our innovations are protected by a number of Patents in various countries. As the digital and mobile technologies evolve, 01 continues to provide cost effective and reliable solutions that give businesses and consumers anytime anywhere remote access to information stored on a desktop computer.

01 Communique Laboratory Inc.

Virtual Non-Deal Roadshow: TSX: CSW.A | CSW.B - Feb 19, 2021

Corby Spirit and Wine Limited is a leading Canadian manufacturer, marketer and distributor of spirits and wines. We own or represent many of the 25 top-selling brands in the country and support our brands with innovative and award-winning marketing campaigns and events. In addition to sales across Canada through our own sales force, Corby products are also exported for sale to the United States, Europe and other international markets.

Corby is a publicly traded company based in Toronto, Ontario, and listed on the Toronto Stock Exchange under the trading symbols CSW.A and CSW.B.

We are affiliated with Pernod Ricard S.A., a global leader in the spirits and wine industry. This partnership has helped expand our portfolio, strengthened our operations and buying power, and allowed us to leverage international know-how and best practices for the benefit of all Corby stakeholders. Corby works closely with Hiram Walker & Sons Ltd., which is also affiliated with Pernod Ricard, where the vast majority of Corby-owned brands are produced, grain to glass, at the historic Hiram Walker facility in Windsor, Ontario. In recent years, Corby has also acquired two rapidly growing Canadian businesses: Ungava Spirits Co. and Foreign Affair Winery.

Our deep commitment to quality, innovation and service has helped the Corby brands become part of traditions and celebrations from coast to coast. It has helped our workforce grow and sales expand in every corner of the country, and it has helped us deliver consistent returns to our shareholders for decades.

Corby Spirit and Wine Limited